We are live on
!
Find out more
HCMNY
Howard Capital Management (New York) Portfolio holdings
AUM
$891M
1-Year Est. Return
34.82%
This Fund
S&P 500
This Quarter
Est. Return
+4.94%
1 Year Est. Return
+34.82%
3 Year Est. Return
+76.77%
5 Year Est. Return
+136.83%
10 Year Est. Return
–
AUM
$508M
AUM Growth
+$216K
(+0.04%)
Cap. Flow
-$22.4M
Cap. Flow
% of AUM
-4.42%
Top 10 Holdings %
Top 10 Hldgs %
33.84%
Holding
114
New
10
Increased
13
Reduced
51
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$6.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.16M |
| 3 |
DaVita
DVA
|
+$417K |
| 4 |
Boeing
BA
|
+$396K |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$299K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McCormick & Company Non-Voting
MKC
|
+$7.82M |
| 2 |
Chevron
CVX
|
+$3.99M |
| 3 |
IMPV
Imperva, Inc.
IMPV
|
+$3.95M |
| 4 |
Apple
AAPL
|
+$1.19M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Industrials | 16.07% |
| 3 | Healthcare | 11.3% |
| 4 | Financials | 8.46% |
| 5 | Energy | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
iShares Biotechnology ETF
IBB
$9.45B
| $21.4M | 4.21% |
249,639
-9,711
| -4% | -$765K |
|
2
Walt Disney
DIS
$171B
| $21.1M | 4.15% |
246,084
-7,875
| -3% | -$643K |
|
3
Merck
MRK
$322B
| $19.4M | 3.82% |
351,136
-9,838
| -3% | -$537K |
|
|
4
State Street SPDR S&P 500 ETF Trust
SPY
$771B
| $17.1M | 3.37% |
87,343
-6,195
| -7% | -$1.18M |
|
|
5
Apple
AAPL
$4.97T
| $16.6M | 3.27% |
715,628
-55,996
| -7% | -$1.19M |
|
6
SLB Ltd
SLB
$72.7B
| $16M | 3.15% |
135,768
-7,000
| -5% | -$721K |
|
7
Johnson & Johnson
JNJ
$640B
| $15.7M | 3.09% |
150,217
-6,013
| -4% | -$608K |
|
8
GE Aerospace
GE
$364B
| $15M | 2.96% |
119,160
-266
| -0.2% | -$33.8K |
|
9
Alphabet (Google) Class C
GOOG
$4.11T
| $14.8M | 2.92% |
512,042
-25,726
| -5% | -$698K |
|
10
Union Pacific
UNP
$174B
| $14.7M | 2.9% |
147,795
-9,405
| -6% | -$911K |
|
11
Microsoft
MSFT
$2.9T
| $13.5M | 2.65% |
323,165
-2,077
| -0.6% | -$84.1K |
|
12
Qualcomm
QCOM
$164B
| $12.8M | 2.53% |
161,991
-9,140
| -5% | -$727K |
|
|
13
Chevron
CVX
$382B
| $11.7M | 2.31% |
89,851
-32,071
| -26% | -$3.99M |
|
14
JPMorgan Chase
JPM
$916B
| $11.6M | 2.29% |
201,874
-5,001
| -2% | -$281K |
|
15
RTX Corp
RTX
$290B
| $11.5M | 2.27% |
158,604
-5,778
| -4% | -$425K |
|
16
American Express
AXP
$224B
| $11.3M | 2.22% |
119,095
-2,835
| -2% | -$256K |
|
17
Nike
NKE
$64.1B
| $10.6M | 2.09% |
273,978
-10,524
| -4% | -$391K |
|
18
Fluor
FLR
$6.54B
| $10.2M | 2.01% |
132,816
-3,445
| -3% | -$263K |
|
19
Goldman Sachs
GS
$289B
| $9.79M | 1.93% |
58,448
-2,629
| -4% | -$424K |
|
20
Vanguard FTSE Emerging Markets ETF
VWO
$117B
| $9.73M | 1.92% |
225,627
+4,026
| +2% | +$170K |
|
21
Coca-Cola
KO
$383B
| $9.72M | 1.91% |
229,522
-7,113
| -3% | -$289K |
|
22
Amazon
AMZN
$2.44T
| $9.12M | 1.8% |
561,800
-6,360
| -1% | -$101K |
|
23
FedEx
FDX
$73B
| $9.11M | 1.79% |
60,180
-3,435
| -5% | -$480K |
|
24
Kimberly-Clark
KMB
$37.6B
| $9.1M | 1.79% |
85,294
-1,116
| -1% | -$119K |
|
25
Intel
INTC
$413B
| $8.84M | 1.74% |
286,078
-8,838
| -3% | -$242K |
|
Similar funds
BII
HCM
LCM
DBC
SWM
DK
AVAX
IVA
Howard Capital Management (New York)'s Q2 2014 Portfolio in Review
As of Q2 2014, Howard Capital Management (New York) held 114 positions worth $508M, up 0.04% from $508M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Howard Capital Management (New York) withdrew a net $22.4M in Q2 2014, closing 6 positions and reducing 51 holdings. Its most notable exit was McCormick & Company Non-Voting, an estimated $7.82M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Howard Capital Management (New York) opened a new position in CVS Health worth $6.88M.
- Howard Capital Management (New York)'s largest Q2 2014 buy was CVS Health: 91,345 shares worth $6.88M.
- Howard Capital Management (New York) added most to Bristol-Myers Squibb in Q2 2014, an estimated $1.16M increase.
- Howard Capital Management (New York)'s biggest Q2 2014 reduction was Chevron, cutting an estimated $3.99M.
- Howard Capital Management (New York) fully exited McCormick & Company Non-Voting in Q2 2014, selling an estimated $7.82M.
- Howard Capital Management (New York)'s ten largest holdings make up 34% of its $508M portfolio in Q2 2014.
- Howard Capital Management (New York) opened 10 new positions and closed 6 in Q2 2014.
- Howard Capital Management (New York)'s portfolio value rose 0.04% quarter-over-quarter to $508M.
Based on Howard Capital Management (New York)'s 13F filing for Q2 2014, filed 16 Jul 2014.